CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Medlumics has developed AblaView™, an optically guided catheter for radiofrequency ablation to treat atrial fibrillation. This technology allows real-time visualization and control of tissue ablation, improving treatment accuracy and patient safety.
Medlumics innovation, AblaView™ is an optically guided radiofrequency (RF) ablation catheter to treat atrial fibrillation and arrhythmias.
The AblaView™ technology is based on Optical Coherence Reflectometry) which in turn allows the Electrophysiologist to view the ablation of precise areas of the myocardial tissue “inside the heart in real time” for the treatment of Atrial fibrillation.Atrial Fibrilation is the most common type of heart arrhythmia.
An estimated 33.5 million people worldwide suf…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
